| Secondary |
| Hypertension |
18.3% |
| Cardiac Failure |
17.5% |
| Drug Use For Unknown Indication |
8.8% |
| Product Used For Unknown Indication |
8.5% |
| Gastritis |
5.6% |
| Cerebral Infarction |
5.0% |
| Atrial Fibrillation |
4.0% |
| Oedema |
3.7% |
| Cardiac Failure Chronic |
3.4% |
| Lumbar Spinal Stenosis |
3.2% |
| Bronchitis |
2.7% |
| Insomnia |
2.7% |
| Headache |
2.4% |
| Hyperuricaemia |
2.4% |
| Urine Output Decreased |
2.4% |
| Glaucoma |
2.1% |
| Prophylaxis |
2.1% |
| Arrhythmia |
1.9% |
| Diabetes Mellitus |
1.9% |
| Diuretic Effect |
1.6% |
|
| Platelet Count Decreased |
11.1% |
| Blood Creatinine Increased |
7.4% |
| Dehydration |
7.4% |
| Renal Impairment |
7.4% |
| Sudden Cardiac Death |
7.4% |
| Toxic Skin Eruption |
7.4% |
| Haemolytic Anaemia |
5.6% |
| Pancytopenia |
5.6% |
| Self-medication |
5.6% |
| Cardiac Failure |
3.7% |
| Face Oedema |
3.7% |
| Feeling Cold |
3.7% |
| Heat Illness |
3.7% |
| Pyrexia |
3.7% |
| Small For Dates Baby |
3.7% |
| Vasculitis |
3.7% |
| Vomiting |
3.7% |
| Acute Myocardial Infarction |
1.9% |
| Acute Prerenal Failure |
1.9% |
| Atrial Fibrillation |
1.9% |
|
| Concomitant |
| Hypertension |
25.7% |
| Cardiac Failure |
9.7% |
| Cardiac Failure Chronic |
7.8% |
| Prophylaxis |
6.8% |
| Product Used For Unknown Indication |
4.4% |
| Diabetes Mellitus |
4.3% |
| Atrial Fibrillation |
4.3% |
| Hyperuricaemia |
3.9% |
| Drug Use For Unknown Indication |
3.8% |
| Constipation |
3.5% |
| Hyperlipidaemia |
3.4% |
| Angina Pectoris |
3.3% |
| Insomnia |
3.3% |
| Type 2 Diabetes Mellitus |
3.2% |
| Pain |
2.7% |
| Cardiac Failure Congestive |
2.3% |
| Gastritis |
2.0% |
| Nephrotic Syndrome |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| Acute Myocardial Infarction |
1.7% |
|
| Renal Impairment |
11.2% |
| Cardiac Failure |
7.8% |
| Interstitial Lung Disease |
7.8% |
| Pneumonia |
7.4% |
| Hepatic Function Abnormal |
6.7% |
| Renal Failure Acute |
5.6% |
| Renal Failure |
5.2% |
| Death |
4.5% |
| Hypoglycaemia |
4.5% |
| Nephrotic Syndrome |
4.1% |
| Renal Failure Chronic |
4.1% |
| Cerebral Haemorrhage |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Cardiac Failure Congestive |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Hyperkalaemia |
3.3% |
| Hypoaesthesia |
3.3% |
| Oedema Peripheral |
3.3% |
| Rhabdomyolysis |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
94.4% |
| Onychomycosis |
5.6% |
|
| Drug Interaction |
50.0% |
| Condition Aggravated |
25.0% |
| Dementia |
25.0% |
|
